Gilead Questions Validity, Enforceability Of HIV Drug Patents
WILMINGTON, Del. — Gilead Sciences Inc. (GSI) fired back at the government on Jan. 23, telling a federal judge in Delaware that not only does it not infringe four patents owned...To view the full article, register now.
Already a subscriber? Click here to view full article